Dr. Mason on the Role of Surgery in Stage III NSCLC

David P. Mason, MD
Published: Tuesday, Apr 30, 2019



David P. Mason, MD, chief of thoracic surgery and lung transplantation, Baylor Scott & White Healthcare System, chief of lung transplantation, Baylor University Medical Center, discusses the role of surgery in stage III non–small cell lung cancer (NSCLC).

A number of factors may prevent patients from seeing a surgeon, even though one-third to one-half of patients with lung cancer require a multimodality approach. For example, a lot of patients present with stage III disease in which the role of surgery is not as well defined as it is in earlier stages.

As far as the conversation between a surgeon and a patient, Mason says he first likes to get a sense of the patient’s overall fitness, motivation, and willingness to undergo an intensive procedure in addition to receiving other medical therapy such as chemoradiation. Additionally, patients have to understand the level of risk associated with surgery, Mason adds.
SELECTED
LANGUAGE


David P. Mason, MD, chief of thoracic surgery and lung transplantation, Baylor Scott & White Healthcare System, chief of lung transplantation, Baylor University Medical Center, discusses the role of surgery in stage III non–small cell lung cancer (NSCLC).

A number of factors may prevent patients from seeing a surgeon, even though one-third to one-half of patients with lung cancer require a multimodality approach. For example, a lot of patients present with stage III disease in which the role of surgery is not as well defined as it is in earlier stages.

As far as the conversation between a surgeon and a patient, Mason says he first likes to get a sense of the patient’s overall fitness, motivation, and willingness to undergo an intensive procedure in addition to receiving other medical therapy such as chemoradiation. Additionally, patients have to understand the level of risk associated with surgery, Mason adds.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
The Patient and Provider Connection™: Effective Communication to Optimize the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic ConstipationOct 31, 20191.0
Publication Bottom Border
Border Publication
x